Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.

https://doi.org/10.1182/hematology.2019000068

Published: 2019

Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 260–265.

https://doi.org/10.1182/hematology.2019000370

Published: 2019

Journal Articles

Biology-driven developments in the therapy of acute graft-versus-host disease

Robert Zeiser

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 236–241.

https://doi.org/10.1182/asheducation-2018.1.236

Published: 2018

Journal Articles

Challenges and implications of genomics for T-cell lymphomas

Eric D. Jacobsen, David M. Weinstock

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 63–68.

https://doi.org/10.1182/asheducation-2018.1.63

Published: 2018

Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.

https://doi.org/10.1182/asheducation-2017.1.618

Published: 2017

Journal Articles

Cardiovascular complications in patients with sickle cell disease

Mark T. Gladwin

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 423–430.

https://doi.org/10.1182/asheducation-2017.1.423

Published: 2017

Journal Articles

New therapeutic targets in transfusion-dependent and -independent thalassemia

M. Domenica Cappellini, Irene Motta

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 278–283.

https://doi.org/10.1182/asheducation-2017.1.278

Published: 2017

Journal Articles

Can we make a better match or mismatch with KIR genotyping?

Rohtesh S. Mehta, Katayoun Rezvani

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 106–118.

https://doi.org/10.1182/asheducation-2016.1.106

Published: 2016

Journal Articles

Using red blood cell genomics in transfusion medicine

Jill M. Johnsen

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 168–176.

https://doi.org/10.1182/asheducation-2015.1.168

Published: 2015

Journal Articles

Recent insights into the role of the contact pathway in thrombo-inflammatory disorders

Maurits L. van Montfoort, Joost C.M. Meijers

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 60–65.

https://doi.org/10.1182/asheducation.V2014.1.60.3882400

Published: 2014

Journal Articles

Impact of MYC on malignant behavior

German Ott

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 100–106.

https://doi.org/10.1182/asheducation-2014.1.100

Published: 2014

Journal Articles

Lasting power of new clotting proteins

Jerry S. Powell

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 355–363.

https://doi.org/10.1182/asheducation-2014.1.355

Published: 2014

Journal Articles

Management of VWD

Anne T. Neff, Robert F. Sidonio, Jr

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 536–541.

https://doi.org/10.1182/asheducation-2014.1.536

Published: 2014

Journal Articles

RBCs as targets of infection

Jeffrey McCullough

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 404–409.

https://doi.org/10.1182/asheducation-2014.1.404

Published: 2014

Journal Articles

Antibody-drug conjugates: the chemistry behind empowering antibodies to fight cancer

Jonathan G. Drachman, Peter D. Senter

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 306–310.

https://doi.org/10.1182/asheducation-2013.1.306

Published: 2013

Journal Articles

Molecular approaches for improved clotting factors for hemophilia

Randal J. Kaufman, Jerry S. Powell

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 30–36.

https://doi.org/10.1182/asheducation-2013.1.30

Published: 2013

Journal Articles

T-cell adoptive immunotherapy for acute lymphoblastic leukemia

Terry J. Fry, Crystal L. Mackall

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 348–353.

https://doi.org/10.1182/asheducation-2013.1.348

Published: 2013

Journal Articles

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Stefan N. Constantinescu, William Vainchenker

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 553–560.

https://doi.org/10.1182/asheducation.V2012.1.553.3800163

Published: 2012

Journal Articles

Haploidentical transplantation for hematologic malignancies: where do we stand?

Ephraim J. Fuchs

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 230–236.

https://doi.org/10.1182/asheducation.V2012.1.230.3798312

Published: 2012

Journal Articles

Using the Biology of Chronic Lymphocytic Leukemia to Choose Treatment

Peter Hillmen

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 104–109.

https://doi.org/10.1182/asheducation-2011.1.104

Published: 2011

NARROW

Myeloma: next generation immunotherapy

CAR T-cell therapy: is it prime time in myeloma?

Biology-driven developments in the therapy of acute graft-versus-host disease

Challenges and implications of genomics for T-cell lymphomas

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Cardiovascular complications in patients with sickle cell disease

New therapeutic targets in transfusion-dependent and -independent thalassemia

Can we make a better match or mismatch with KIR genotyping?

Using red blood cell genomics in transfusion medicine

Recent insights into the role of the contact pathway in thrombo-inflammatory disorders

Impact of MYC on malignant behavior

Lasting power of new clotting proteins

Management of VWD

RBCs as targets of infection

Antibody-drug conjugates: the chemistry behind empowering antibodies to fight cancer

Molecular approaches for improved clotting factors for hemophilia

T-cell adoptive immunotherapy for acute lymphoblastic leukemia

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Haploidentical transplantation for hematologic malignancies: where do we stand?

Using the Biology of Chronic Lymphocytic Leukemia to Choose Treatment

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only